Annual ROE
-69.00%
+31.37%+31.25%
December 31, 2023
Summary
- As of February 10, 2025, LABP annual return on equity is -69.00%, with the most recent change of +31.37% (+31.25%) on December 31, 2023.
- During the last 3 years, LABP annual ROE has fallen by -124.81% (-223.63%).
Performance
LABP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-73.00%
-18.08%-32.92%
March 31, 2024
Summary
- As of February 10, 2025, LABP quarterly return on equity is -73.00%, with the most recent change of -18.08% (-32.92%) on March 31, 2024.
- Over the past year, LABP quarterly ROE has dropped by -22.61% (-44.87%).
Performance
LABP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LABP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.3% | -44.9% |
| 3 y3 years | -223.6% | +97.9% |
| 5 y5 years | +88.6% | -632.5% |
LABP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +400.5% | +79.1% | +26.8% |
| 5 y | 5-year | -223.6% | +400.5% | -214.2% | +4692.1% |
| alltime | all time | -223.6% | +775.9% | -214.2% | +4692.1% |
Landos Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | -73.00%(+32.9%) |
| Dec 2023 | -69.00%(-31.3%) | -54.92%(+9.0%) |
| Sep 2023 | - | -50.39%(-5.4%) |
| Jun 2023 | - | -53.24%(-20.6%) |
| Mar 2023 | - | -67.03%(-16.0%) |
| Dec 2022 | -100.37%(-70.9%) | -79.84%(-13.8%) |
| Sep 2022 | - | -92.58%(+11.6%) |
| Jun 2022 | - | -82.94%(+61.2%) |
| Mar 2022 | - | -51.46%(+26.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | -345.32%(-718.7%) | -40.77%(-15.2%) |
| Sep 2021 | - | -48.10%(-48.4%) |
| Jun 2021 | - | -93.21%(-97.3%) |
| Mar 2021 | - | -3498.23%(-5801.2%) |
| Dec 2020 | 55.81%(+6.0%) | 61.36%(-4.0%) |
| Sep 2020 | - | 63.91%(+16.1%) |
| Jun 2020 | - | 55.04%(+51.3%) |
| Mar 2020 | - | 36.37%(+165.3%) |
| Dec 2019 | 52.64%(-108.7%) | 13.71% |
| Dec 2018 | -604.40% | - |
FAQ
- What is Landos Biopharma annual return on equity?
- What is the all time high annual ROE for Landos Biopharma?
- What is Landos Biopharma annual ROE year-on-year change?
- What is Landos Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Landos Biopharma?
- What is Landos Biopharma quarterly ROE year-on-year change?
What is Landos Biopharma annual return on equity?
The current annual ROE of LABP is -69.00%
What is the all time high annual ROE for Landos Biopharma?
Landos Biopharma all-time high annual return on equity is 55.81%
What is Landos Biopharma annual ROE year-on-year change?
Over the past year, LABP annual return on equity has changed by +31.37% (+31.25%)
What is Landos Biopharma quarterly return on equity?
The current quarterly ROE of LABP is -73.00%
What is the all time high quarterly ROE for Landos Biopharma?
Landos Biopharma all-time high quarterly return on equity is 63.91%
What is Landos Biopharma quarterly ROE year-on-year change?
Over the past year, LABP quarterly return on equity has changed by -22.61% (-44.87%)